Rahul Kesarwani

4PUBLICATIONS
9CO-AUTHORS
Cancer cell biologyNatural products and bioactive compoundsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 27, 2026
Stimuli-responsive fluorogenic prodrugs of potent inhibitors targeting overexpressed metabolic enzymes in cancer.

|Feb 28, 2025
Synthetic organic polysulfanes as H<sub>2</sub>S donors and anticancer agents.

Abu Sufian, Debojit Bhattacherjee, Pallavi Barman

|Apr 11, 2024
Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders.

Abu Sufian, Nidhi Parihar, Md Badirujjaman

|Feb 26, 2024
Stimuli-responsive biotin-anchored prodrug for the targeted delivery of anti-cancer agent NBDHEX with turn-on NIR fluorescence.

Rahul Kesarwani, Nikita Pal, Krishna P Bhabak

Pageof 1

Frequent Collaborators

4 joint publications

Krishna P Bhabak

3 joint publications

Pallavi Barman

2 joint publications

Nikita Pal

2 joint publications

Abu Sufian